Tracy Danneker

Sr. Business Developent Executive
Thermo Fisher Scientific

Since 2022, I have supported Oral Drug Delivery at Thermo Fisher Scientific, working closely with pharmaceutical and biotech partners to advance small molecule development from early-phase through commercialization. I’m deeply committed to enabling my client's success by providing strategic guidance and seamless support throughout the drug development lifecycle- ultimately helping to deliver life-changing therapies to patients.  

Disclosure information not submitted.

Presentation(s):

• Industry Roundtable: Critical considerations, challenges, opportunities and strategies in development of once a day (QD) formulations

  Wednesday, July 16, 2025
  1:00 PM - 2:30 PM EDT